Ir para o conteúdo principal

Grafa News and Videos — Page 1046

Destaques de Grafa

Grafa

FDA grants priority review to Merck’s Keytruda combo for muscle-invasive bladder cancer

Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for two supplemental Biologics License Applications (sBLA) involving its anti-PD-1 therapy, Keytruda.

Leia mais: FDA grants priority review to Merck’s Keytruda combo for muscle-invasive bladder cancer

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas